Kyle Begovich

Kyle Begovich is a Senior Scientist at Pfizer, bringing over 13 years of research experience in translational oncology and neurodegeneration. Previously, they held positions as Principal Scientist at Biotheryx, Inc., where they led the SOS1 bifunctional degrader program, and as a Postdoctoral Researcher at GNF, where they developed high-throughput biochemical assays. Kyle earned a PhD in Cell/Cellular and Molecular Biology from the University of California San Diego, where they engaged in significant research, including the investigation of stress granule assembly. Their work has been published in several prominent journals, showcasing their contributions to the field.